2m 2m 2m 2m 2m 2m 2m
Protagonist Ther (PTGX)
NASDAQ
$131.00+$1.11 (+0.85%)
Price as of Jul 14, 2026 5:39 AM EDT- $8.4BMarket Cap
- 135.18%1-Year Change
- BiotechnologyIndustry
Protagonist Ther (PTGX)
$131.00+$1.11 (+0.85%)
Earnings Score
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 3.60% | ||
12-Month Momentum | 99.57% | ||
3-Month Risk Adjusted Momentum | 16.89% | ||
12-Month Risk Adjusted Momentum | 200.75% |
True Yield
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | -0.52% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | PTGX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 3 |